|
|
Article: Barr Receives Approval for Generic XANAX XR(R) Tablets.
- Article from:
- PR Newswire
- Article date:
- August 1, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WOODCLIFF LAKE, N.J., Aug. 1 /PRNewswire-FirstCall/ -- Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. , today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its application to manufacture and market a generic version of Pfizer Inc.'s XANAX XR(R) (Alprazolam Extended-Release) Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The Company intends to launch its product immediately.
XANAX XR Tablets are indicated for the treatment of panic disorder, with or without agoraphobia.
Barr's Alprazolam Extended-Release tablets will compete in a market that had total annual sales of approximately $83 million ...